Prudential plc’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,534
Closed -$1.58M 772
2024
Q1
$1.58M Sell
18,534
-27,760
-60% -$2.18M 0.01% 438
2023
Q4
$3.96M Buy
+46,294
New +$4M 0.04% 286
2018
Q4
Sell
-1,800
Closed -$206K 711
2018
Q3
$206K Buy
+1,800
New +$186K ﹤0.01% 694
2016
Q3
Sell
-11,008
Closed -$319K 636
2016
Q2
$319K Sell
11,008
-258,365
-96% -$7.81M ﹤0.01% 543
2016
Q1
$9.42M Sell
269,373
-3,607
-1% -$116K 0.04% 272
2015
Q4
$8.8M Sell
272,980
-150,709
-36% -$4.89M 0.04% 276
2015
Q3
$13.7M Sell
423,689
-123,511
-23% -$4.65M 0.06% 225
2015
Q2
$22.6M Sell
547,200
-409,628
-43% -$17.3M 0.09% 194
2015
Q1
$43M Sell
956,828
-168,304
-15% -$7.04M 0.19% 144
2014
Q4
$42.1M Sell
1,125,132
-63,283
-5% -$2.32M 0.18% 146
2014
Q3
$41.5M Sell
1,188,415
-155,176
-12% -$5.54M 0.17% 143
2014
Q2
$47.4M Sell
1,343,591
-374,947
-22% -$12.5M 0.2% 138
2014
Q1
$56M Sell
1,718,538
-171,804
-9% -$6.57M 0.25% 112
2013
Q4
$79.6M Sell
1,890,342
-187,795
-9% -$7.73M 0.34% 87
2013
Q3
$82.9M Sell
2,078,137
-49,963
-2% -$2.1M 0.42% 71
2013
Q2
$88M Buy
+2,128,100
New +$86.2M 0.48% 72

Other funds holding HAE

Prudential plc's HAE Position: Q2 2024 in Review

Prudential plc sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 18,534 shares — an estimated $1.58M sold.

Prudential plc first reported a position in HAE in Q2 2013 and held it in 16 quarters. The position peaked at $88M in Q2 2013. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Prudential plc reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Prudential plc sold 18,534 Haemonetics shares in Q2 2024, an estimated $1.58M.
  • Prudential plc first reported a position in Haemonetics in Q2 2013 and held it in 16 quarters.
  • Prudential plc's Haemonetics position peaked at $88M in Q2 2013.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Prudential plc's 13F filing for Q2 2024, filed 7 Aug 2024.